+++
name = "KLH40"
target = "DDHD2"
activity = "Control compound for <a href='#klh45' class='js-scroll-trigger'>KLH45</a>"
pubchem_cid = "132274141"
cas = "-"
systematic_name = "(R)-(3-benzylmorpholino)(4-(4-(trifluoromethoxy)phenyl)-1H-1,2,3-triazol-1-yl)methanone"
synonyms = []
molecular_weight = "432.40"


[[references]]
authors_list = "Inloes, J. M., Hsu, K.-L., Dix, M. M., Viader, A., Masuda, K., Takei, T., Wood, M. R., and Cravatt, B. F."
title = "The hereditary spastic paraplegia-related enzyme DDHD2 is a principal brain triglyceride lipase"
journal = "Proc. Natl. Acad. Sci. U.S.A."
year = 2014
volume = 111
pages = "14924-14929"
doi_link = "https://doi.org/10.1073/pnas.1413706111"
pubmed_link = "https://www.ncbi.nlm.nih.gov/pubmed/25267624"

+++

KLH40 is a control compound for <a href="#klh45" class="js-scroll-trigger">KLH45</a> that reacts with ABHD6 with similar potency as the DDHD2 inhibitor <a href="#klh45" class="js-scroll-trigger">KLH45</a> . KLH40 can be used to control for the ABHD6 off-target activity of <a href="#klh45" class="js-scroll-trigger">KLH45</a>, in cells (Neuro2a, IC50 ~ 10 nM) and in mice (20 mg⋅kg<sup>−1</sup>, i.p., every 12 h, 4 days).
